Correlation of functional GRIN2A gene promoter polymorphisms with schizophrenia and serum d-serine levels

Gene

Volumn 568, Issue 1, 2015, Pages 25-30

  Liu, Rui ^a   Dang, Wei ^b   Du, Ying ^a   Zhou, Qiong ^a   Liu, Zhaohui ^a   Jiao, Kai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Mental Health Center   (China)

Author keywords

D Serine; GRIN2A; GT; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

DEXTRO SERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A; SERINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE REPRESSION; GENETIC PARAMETERS; GENOTYPE; HAN CHINESE; HARDY WEINBERG EQUILIBRIUM; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; BLOOD; CASE CONTROL STUDY; CHINA; DINUCLEOTIDE REPEAT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CHINA; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SERINE;

EID: 84930870155     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.05.011     Document Type: Article

References (31)

1. Association A.P. Diagnostic and Statistical Manual of Mental Disorders, (DSM-5®) 2013, American Psychiatric Pub.
2. Castellano C., Cestari V., Ciamei A. NMDA receptors and learning and memory processes. Curr. Drug Targets 2001, 2:273-283.
3. Celso Constantino L., Tasca C.I., Boeck C.R. The role of NMDA receptors in the development of brain resistance through pre- and postconditioning. Aging Dis. 2014, 5:430-441.
4. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 1995, 15:6498-6508.
5. Clinton S.M., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 2003, 160:1100-1109.
6. Collin L., Bindra J., Raju M., Gillberg C., Minnis H. Facial emotion recognition in child psychiatry: a systematic review. Res. Dev. Disabil. 2013, 34:1505-1520.
7. Fukushima T., Kawai J., Imai K., Toyo'oka T. Simultaneous determination of d- and l-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed. Chromatogr. 2004, 18:813-819.
8. Hashimoto K., Fukushima T., Shimizu E., Komatsu N., Watanabe H., Shinoda N., Nakazato M., Kumakiri C., Okada S., Hasegawa H., Imai K., Iyo M. Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry 2003, 60:572-576.
9. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., Iyo M. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:767-769.
10. Heresco-Levy U., Javitt D.C., Ebstein R., Vass A., Lichtenberg P., Bar G., Catinari S., Ermilov M. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol. Psychiatry 2005, 57:577-585.
11. Horak M., Petralia R.S., Kaniakova M., Sans N. ER to synapse trafficking of NMDA receptors. Front. Cell. Neurosci. 2014, 8:394.
12. Ibrahim H.M., Hogg A.J., Healy D.J., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry 2000, 157:1811-1823.
13. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J. Biol. Chem. 1993, 268:2836-2843.
14. Itokawa M., Yamada K., Iwayama-Shigeno Y., Ishitsuka Y., Detera-Wadleigh S., Yoshikawa T. Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans. Neurosci. Lett. 2003, 345:53-56.
15. Itokawa M., Yamada K., Yoshitsugu K., Toyota T., Suga T., Ohba H., Watanabe A., Hattori E., Shimizu H., Kumakura T., Ebihara M., Meerabux J.M., Toru M., Yoshikawa T. A microsatellite repeat in the promoter of the N-methyl-d-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics 2003, 13:271-278.
16. Iwayama Y., Hashimoto K., Nakajima M., Toyota T., Yamada K., Shimizu E., Itokawa M., Hoshika A., Iyo M., Yoshikawa T. Analysis of correlation between serum d-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes. Neurosci. Lett. 2006, 394:101-104.
17. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992, 256:1217-1221.
18. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991, 354:31-37.
19. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., Rogawski M.A., Snyder S.H. d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4926-4931.
20. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992, 258:597-603.
21. Nishi M., Hinds H., Lu H.P., Kawata M., Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J. Neurosci. 2001, 21:RC185.
22. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., Oliet S.H. Glia-derived d-serine controls NMDA receptor activity and synaptic memory. Cell 2006, 125:775-784.
23. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 2001, 299:12-20.
24. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 1995, 15:6509-6520.
25. Tang J., Chen X., Xu X., Wu R., Zhao J., Hu Z., Xia K. Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-d-aspartate receptor subunit gene (GRIN2A) and schizophrenia. Neurosci. Lett. 2006, 409:80-82.
26. Thomson P.A., Malavasi E.L., Grunewald E., Soares D.C., Borkowska M., Millar J.K. DISC1 genetics, biology and psychiatric illness. Front. Biol. (Beijing) 2013, 8:1-31.
27. Timms A.E., Dorschner M.O., Wechsler J., Choi K.Y., Kirkwood R., Girirajan S., Baker C., Eichler E.E., Korvatska O., Roche K.W., Horwitz M.S., Tsuang D.W. Support for the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry 2013, 70:582-590.
28. Tsai G.E., Lin P.Y. Strategies to enhance N-methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr. Pharm. Des. 2010, 16:522-537.
29. Tsai G., Yang P., Chung L.C., Lange N., Coyle J.T. d-serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 1998, 44:1081-1089.
30. Wang F., Chen H., Steketee J.D., Sharp B.M. Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 2007, 32:103-109.
31. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol. Psychiatry 2005, 57:1493-1503.